Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

BGU Develops "Smart" Drugs to Reduce Inflammation

July 23, 2015 8:27 am | by Ben-Gurion University of the Negev | News | Comments

The uniqueness of this novel anti-inflammatory molecule can be found in a singular property. Read more...


Roche Diagnostics Adds New HTLV-I/II Assay to Blood Screening Portfolio

July 23, 2015 8:26 am | News | Comments

The test enhances Roche’s blood screening portfolio in serology testing. Read more...


J&J to Challenge Novartis in Axial Spondyloarthritis Treatment Space

July 23, 2015 8:25 am | by Heather Leach, Ph.D., Senior Immunology Analyst, GlobalData | News | Comments

The anticipated launches of Novartis’ Cosentyx and J&J’s Stelara will add new mechanisms of action to the existing axSpA treatment space. Read more...


Identifying Biomarkers Key to Early Intervention in Alzheimer's Disease

July 22, 2015 1:39 pm | by University of Kentucky | News | Comments

Although the term didn’t surface until the 1980s, the concept of biomarkers has been around for almost a century.  Today, doctors routinely test blood for signs of anemia or the antigen associated with prostate cancer.  Urine samples can hint at the presence of infection or diabetes, and EEGs diagnose electrical abnormalities in the brain. Read more...


Court Ruling Clears Way for Novartis' Low-Cost Biotech Drug

July 22, 2015 1:35 pm | by Associated Press | News | Comments

A federal appeals court has ruled that Novartis can begin selling its lower-cost copy of an Amgen Inc. drug in September, rejecting a bid to further delay the launch of the knock-off biotech medication. Read more...


Pfizer Is Expanding Its Vaccine Portfolio, Developing Others

July 22, 2015 1:27 pm | by Associated Press | News | Comments

Pfizer has expanded its research on vaccines to eventually safeguard people from cradle to grave, from shots for pregnant women to protect their babies from the moment of birth to vaccines for senior citizens with waning immune systems, company officials said Tuesday during a media briefing. Read more...


New Data on Lilly, Biogen Alzheimer’s Drugs Show Mixed Results

July 22, 2015 1:00 pm | by Stephanie Guzowski, Editor | News | Comments

After much anticipation, new data was released today: Eli Lilly’s experimental drug showed consistently improved results the longer patients took its drug, while Biogen’s yielded stronger efficacy the higher the dose. However, Biogen’s most effective dose, the highest one, had a high rate of a brain-swelling side effect. Read more...


Four Pharma Firms Create Potential Blockbuster Migraine Drugs

July 22, 2015 11:21 am | by Ryan Bushey, Associate Editor | News | Comments

The market for an effective migraine therapy is worth billions. Read more...


Diabetes Drug May Protect Against Parkinson's Disease

July 22, 2015 8:54 am | by London School of Hygiene & Tropical Medicine | News | Comments

A type of drug used to treat diabetes may reduce the risk of developing Parkinson’s disease. Read more...


Gilead: Phase 3 Results for Study Evaluating Switch from TDF-Based Regimens to TAF-Based Regimens

July 22, 2015 8:45 am | News | Comments

The study met its primary endpoint by demonstrating non-inferiority of E/C/F/TAF to the TDF-based regimens at Week 48. Read more...


U.S., China Will Drive Cancer Companion Diagnostics Market Value to $670M by 2020

July 22, 2015 8:31 am | by Andrew S. Thompson, Ph.D., Senior In Vitro Diagnostics Analyst, GlobalData | Articles | Comments

Other significant drivers of cancer companion diagnostics market growth include increasing disease incidence, accelerating demand for targeted therapies and economic pressures to develop maximally efficient treatments. Read more...


Horizon Pharma Raises Bid for Depomed to $33 Per Share

July 22, 2015 8:29 am | by The Associated Press | News | Comments

The Dublin-based company said Tuesday that the new offer is contingent on Depomed entering "good faith" talks on the transaction. Read more....


Untreatable Eczema Beat with Arthritis Drug, Yale Researchers Say

July 22, 2015 8:29 am | by Seth Augenstein, Digital Reporter | News | Comments

An arthritis drug can beat chronic eczema, according to a new study by Yale researchers. Tofacitinib citrate, used for rheumatoid arthritis, led to dramatic improvement in eczema in six patients with moderate to severe forms of the chronic ailment, who had previously tried conventional treatments without improvement, according to the study. Read more...


Aspirin’s Myriad Effects on Breast Cancer

July 22, 2015 8:20 am | by Cynthia Fox, Science Editor | Articles | Comments

A July Laboratory Investigation report found aspirin may render the environment of cancer stem cells, which can linger post-chemo, hostile to replication. Aspirin may also ward off breast cancer prophylactically, according to the study led by Sushanta Banerjee, Ph.D., research director of the Cancer Research Unit at the Kansas City (Mo.) Veterans Affairs Medical Center. Read more...


Delcath Receives Orphan Drug Designation To Treat Cholangiocarcinoma

July 21, 2015 1:12 pm | News | Comments

Delcath Systems, Inc., a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announced today that the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) has granted Orphan Drug Designation for  melphalan  for the treatment of  cholangiocarcinoma. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.